Streptococcus Anginosus: Causes, Symptoms, and Treatment

Streptococcus anginosus is a bacterium that normally lives harmlessly in your mouth, throat, and gut but can cause serious deep-seated infections, particularly abscesses, when it reaches places it doesn’t belong. It belongs to a small family of three closely related species collectively known as the Streptococcus anginosus group (SAG), and what sets this group apart from most other streptococci is a striking tendency to form pus-filled collections in organs throughout the body. Reports of life-threatening SAG infections have been increasing, and the bacterium is now considered an emerging opportunistic pathogen rather than a harmless bystander.

What the Streptococcus Anginosus Group Actually Is

The name “Streptococcus anginosus” can refer to a single species or, somewhat confusingly, to the broader group it headlines. The Streptococcus anginosus group includes three distinct species: S. anginosus, S. intermedius, and S. constellatus.¹ You may also see the group called the “Streptococcus milleri group,” an older name that persists in some clinical settings. These three species sit within the larger viridans streptococci, a broad collection of streptococcal bacteria that tend to live on mucosal surfaces. Genetic analysis using multiple housekeeping genes has confirmed these species as genuinely distinct clusters, each with their own subspecies.²

Each species has a slightly different personality in the clinic. S. intermedius tends to show up more often in deep tissue infections such as brain and liver abscesses. S. constellatus is frequently isolated from respiratory infections and empyema. S. anginosus itself is the most commonly recovered of the three overall and pops up across a wide range of body sites. In children, S. constellatus has been reported as the most frequently isolated SAG species, followed by S. anginosus and then S. intermedius.³

How a Normal Mouth Bacterium Turns Dangerous

Under ordinary circumstances, SAG bacteria are part of your normal flora. They colonize the mouth, the upper respiratory tract, the gastrointestinal tract, and the urogenital tract without causing trouble. The shift from commensal to pathogen happens when these bacteria gain access to normally sterile sites, usually through a breach in mucosal barriers. Poor oral hygiene is a classic entry point: gum disease, tooth abscesses, or dental procedures can allow S. anginosus to enter the bloodstream and seed distant organs.⁴

Once the bacteria reach a vulnerable tissue, their distinctive virulence kicks in. SAG organisms are strongly associated with purulent (pus-forming) infections and abscess formation.⁵ They produce enzymes that break down surrounding tissue and help wall off the infection in a pocket of pus. This abscess-forming habit is the hallmark that separates SAG from most other streptococci and is the reason clinicians pay attention when these organisms grow in culture.

Research into the genomic diversity of S. anginosus helps explain why some strains cause mild infections while others cause shock and organ failure. A comparative analysis of 355 S. anginosus genomes found an enormous gap between the number of core genes shared by all strains (about 900) and the total gene pool across strains (over 8,300), reflecting significant strain-to-strain variation.⁶ In practical terms, one strain of S. anginosus can carry a very different set of virulence tools than another, which is partly why clinical outcomes range from easily treated abscesses to life-threatening septic shock.

Who Is Most at Risk

SAG infections can strike otherwise healthy people, but they are far more common in those with underlying conditions that weaken the immune system or disrupt mucosal barriers. In a study of 463 patients with SAG infections, nearly half had a major underlying disease. The most common conditions were diabetes (about a third of those with comorbidities), solid tumors (roughly 30%), chronic kidney failure, and neurological diseases such as stroke or brain trauma.⁷ Patients on immunosuppressive medications, including those with autoimmune diseases treated with steroids, also appeared at elevated risk.

Beyond systemic conditions, local anatomic factors matter. A history of ear infections, sinus disease, dental decay, or gastrointestinal conditions like diverticulitis can create the mucosal disruption SAG needs to invade. In one reported case, a liver abscess was traced back to sigmoid diverticulitis as the source of bacterial seeding.⁸ Alcohol use and chronic lung disease are additional risk factors that appear frequently in case series of thoracic SAG infections.

Symptoms by Infection Site

Because SAG can infect nearly any organ, the symptoms depend entirely on where the abscess forms. There is no single “SAG infection” presentation. Instead, clinicians encounter a range of site-specific syndromes unified by the common thread of pus formation.

Lung and Pleural Infections

The chest is one of the most common sites for SAG disease. Studies across multiple countries have found that SAG accounts for roughly 30 to 50 percent of community-acquired empyema cases in adults.⁹ Empyema is a collection of pus in the space between the lung and the chest wall, and it is a particularly dangerous complication because it can compress the lung and make breathing difficult. In one clinical series, about three-quarters of patients with SAG respiratory infections developed pleural effusion (fluid around the lung), and half of those effusions progressed to frank empyema.¹⁰ These infections were seen mostly in men with preexisting health conditions. Symptoms typically include persistent fever, chest pain that worsens with breathing, cough, and sometimes sudden deterioration if a lung abscess ruptures into the pleural space.¹¹

Brain Abscesses

SAG is a well-recognized cause of brain abscesses, and these infections can be deceptive in their early presentation. In a case series of three patients with community-acquired brain abscesses caused by SAG, the initial symptoms ranged from high fever with confusion and vomiting to nothing more than two days of dizziness. One patient’s brain abscess was initially mistaken for a metastatic tumor on imaging before surgery revealed pus.¹² In children, central nervous system SAG infections can be devastating. A pediatric case series found abscesses in four patients and empyema inside the skull in one, with S. intermedius identified in most cases. One child, an 8-year-old with a delayed diagnosis, died from brain herniation.¹³ Ear infections and sinusitis are common precursors to SAG brain abscesses, because the bacteria can spread from the middle ear or sinuses directly into the cranial cavity.

Liver and Abdominal Abscesses

The liver is another favorite target. SAG can reach the liver through the bloodstream after entering via the mouth or gut, or it can spread from an adjacent abdominal infection. Patients typically present with fever, right upper abdominal pain, and general malaise. Multiple liver abscesses can form, and management usually requires both prolonged antibiotics and drainage of larger collections.¹⁴ Other abdominal manifestations include peritonitis and subphrenic abscesses (collections under the diaphragm). Because SAG is not always the first organism clinicians suspect in abdominal infections, diagnosis can be delayed.

Heart Valve Infections

Infective endocarditis caused by SAG is uncommon but serious. A multicenter study of 72 cases found that SAG endocarditis most often affected men (76% of cases) with an average age of 67, predominantly involved native heart valves (about 80% of cases), and was overwhelmingly community-acquired rather than hospital-acquired.¹⁵ Complications were common: about a fifth of patients suffered intracranial hemorrhage, a similar proportion had splenic emboli, and roughly a third developed acute heart failure. Overall mortality was about 14%, with all deaths attributable to the endocarditis itself. Even structural heart abnormalities like a bicuspid aortic valve can serve as a nidus for SAG to establish an infection on the valve surface.¹⁶

Skin, Soft Tissue, and Pediatric Presentations

In children, skin and soft tissue infections are the most common SAG presentation, followed by head and neck infections and intra-abdominal abscesses. In a pediatric cohort, more than half of affected children had a predisposing factor such as recent surgery, a chronic illness, or an anatomic abnormality. About three-quarters required surgical drainage in addition to antibiotics, and actual bloodstream infection (bacteremia) was rare.³

Treatment Approaches

The good news is that SAG bacteria remain broadly susceptible to the antibiotics most commonly used against streptococcal infections. Beta-lactam antibiotics, particularly penicillin and cephalosporins, are the backbone of therapy. One tertiary-care study found overall penicillin susceptibility of about 91% among SAG isolates, making beta-lactams the drug of choice.¹⁷ Among the cephalosporins, ceftriaxone is generally preferred because of its strong tissue penetration and the convenience of once-daily dosing. For patients who are allergic to penicillin and related drugs, vancomycin is the standard alternative.¹⁸

Treatment duration is longer than for many other streptococcal infections precisely because of the abscess-forming tendency. Deep-seated abscesses and endocarditis cases typically call for four to six weeks of intravenous antibiotics. In the brain abscess case series mentioned earlier, all three patients were treated with ceftriaxone for a six-week course.¹² For endocarditis, a combination of a beta-lactam with an aminoglycoside like gentamicin was used in about half of cases in one multicenter study, with an average treatment duration of about 35 days.¹⁵

Antibiotics alone are often not enough. Because SAG infections tend to wall themselves off inside abscesses, the drugs have difficulty penetrating the pus-filled cavity at adequate concentrations. Surgical or percutaneous drainage is frequently required. In the pediatric cohort discussed above, about three-quarters of children needed drainage alongside their antibiotics.³ For lung abscesses that rupture into the pleural space, chest tube drainage is typically necessary. Brain abscesses may require stereotactic aspiration or open surgical drainage depending on their size and location.

When infections involve the abdomen, clinicians should consider broadening antibiotic coverage beyond SAG alone, because abdominal collections frequently harbor a mix of bacteria including anaerobes and gram-negative organisms.¹⁷

Antibiotic Resistance Trends

While penicillin resistance remains rare in SAG overall, it is not entirely absent. A German study of 141 SAG isolates found that all were technically susceptible to penicillin, but about 13% showed slightly elevated minimum inhibitory concentrations, a signal that reduced susceptibility could be developing. Resistance to erythromycin (a macrolide antibiotic) was found in about 6% of isolates, and a small number showed resistance to ciprofloxacin as well. All isolates remained susceptible to cefotaxime and vancomycin.¹⁹ The practical takeaway is that penicillins and cephalosporins still work well for SAG, but macrolide resistance is worth watching, particularly in regions with heavy macrolide use.

Challenges in Identifying SAG in the Lab

Correctly identifying SAG bacteria to the species level can be tricky, and this matters because different species have different clinical tendencies. Modern labs increasingly rely on a technology called MALDI-TOF mass spectrometry, which identifies bacteria by analyzing their protein profiles. This method correctly identifies SAG isolates to the species level in about 92 to 93 percent of cases, a substantial improvement over older biochemical testing methods, which managed only around 68 percent accuracy.²⁰ One persistent weak spot is S. intermedius, which is reliably identified by MALDI-TOF in only about 22 percent of cases, even with optimized sample preparation.²¹ Since S. intermedius is the species most associated with deep tissue and brain infections, this gap in identification is clinically frustrating. Molecular methods like multiplex PCR can achieve near-perfect species-level identification but are not available in every hospital laboratory.

Polymicrobial Infections and Why SAG Rarely Acts Alone

SAG infections are frequently polymicrobial, meaning the abscess or infected tissue contains multiple bacterial species alongside SAG. This is particularly true in abdominal and pulmonary infections, where anaerobic bacteria and gram-negative organisms are common co-inhabitants. What makes this especially interesting is recent evidence that S. anginosus may actively help its co-infecting partners survive. Research has shown that S. anginosus produces enzymes that break down neutrophil extracellular traps (NETs), which are web-like structures your immune cells deploy to catch and kill bacteria. By dismantling these traps, S. anginosus not only protects itself but also shields other more dangerous bacteria sharing the infection site.²² This cooperative behavior has implications for treatment, since addressing SAG alone might not resolve a mixed infection.

A Possible Link to Gastric Cancer

One of the more unexpected developments in SAG research is the emerging connection between S. anginosus and gastric cancer. Most people associate stomach cancer with Helicobacter pylori, but recent studies have found that S. anginosus is enriched in gastric cancer tissue compared to healthy stomach lining, and that high abundance of the bacterium is associated with poorer prognosis.²³ Researchers have proposed a mechanism involving succinate, a metabolic byproduct of S. anginosus, that may promote tumor progression through specific signaling pathways in gastric cells. A broader review of the evidence describes a “strong association” between S. anginosus and both malignant progression and unfavorable outcomes in gastric cancer.²⁴

This research is still in relatively early stages, and no one is suggesting that S. anginosus alone causes stomach cancer the way H. pylori does. The relationship may be one where the bacterium thrives in the altered environment of a cancerous stomach and then accelerates disease progression, rather than initiating cancer in the first place. It is a finding worth following, though, especially for clinicians managing patients with unexplained or aggressive gastric disease who also culture SAG.

When to Suspect SAG and What to Tell Your Doctor

SAG infections are probably underdiagnosed. Because the bacteria are part of normal flora, a positive culture from a non-sterile site like the mouth or throat might be dismissed as contamination. And because SAG abscesses can develop slowly, the initial symptoms (low-grade fever, vague pain, fatigue) can be mistaken for something less serious. A few patterns are worth keeping in mind if you or someone you know is dealing with an unexplained deep infection.

If you have a persistent fever and imaging reveals an abscess, particularly in the liver, brain, or lung, SAG should be on the differential diagnosis even if you are otherwise healthy. If you have underlying conditions like diabetes, cancer, or chronic kidney disease and develop a new abscess, SAG is especially worth considering. A history of recent dental problems, dental work, or poor oral hygiene adds further reason to suspect these organisms. And if cultures grow SAG from a deep abscess, the treatment plan should include a conversation about drainage rather than relying on antibiotics alone, because these organisms build abscesses that antibiotics penetrate poorly without physical drainage.

The fact that SAG remains susceptible to common antibiotics is reassuring, but the bacteria’s talent for forming walled-off collections of pus means that identifying the infection early and intervening with both drugs and drainage gives you the best chance of a straightforward recovery. Delayed diagnosis, as the fatal pediatric case illustrates, can turn a treatable infection into a catastrophic one.